CRISPR-based ecDNA induction reveals the role of both NHEJ and MMEJ in ecDNA formation and demonstrates that ecDNA and corresponding chromosomal deletions form at distinct rates and respond differently to pharmacologic modulation.
Dr. Brian Wolpin discusses updated safety and efficacy results from the Phase 1 study of RMC-6236, a RAS(ON) multi-selective inhibitor, highlighting its promising activity, manageable…
The addition of chemotherapy to radiation therapy following surgery conferred a benefit in certain endometrial cancer molecular subtypes.
Members of the Fox Chase Cancer Center community gathered on January 21, 2025 for the Paul J. Grotzinger, MD, Memorial Lecture.
Blood Podcast | Blood | American Society of Hematology Blood Podcast The editors of Blood are pleased to introduce a podcast series, published weekly…
The FIBI technology, created by Farzad Fereidouni, PhD, when combined with AI eliminates the need for frozen sections and other labor-intensive oncology surgery practices.
Researchers compared responses from ChatGPT on colon cancer with expert opinion from oncology clinicians.
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!
In case you missed any, read a recap of the episodes of OncLive On Air that aired in January 2025.
The association of CAR T-cell therapies with second primary cancers warrants the development and examination of mitigation strategies for these toxic effects.
CARGO Therapeutics announced that it will discontinue the phase 2 FIRCE-1 trial evaluating firi-cel in relapsed/refractory large B-cell lymphoma.
